8124849

Source:http://linkedlifedata.com/resource/pubmed/id/8124849

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0022860, umls-concept:C0028778, umls-concept:C0034785, umls-concept:C0450442
pubmed:issue	1
pubmed:dateCreated	1994-4-12
pubmed:abstractText	Labetalol, a compound that blocks both alpha- and beta-adrenergic receptors, is the only drug of its class currently available in the United States.
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/8703441
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Labetalol
pubmed:status	MEDLINE
pubmed:issn	0891-1150
pubmed:author	pubmed-author:PearceC JCJ, pubmed-author:WallinJ DJD
pubmed:issnType	Print
pubmed:volume	61
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	59-69; quiz 80-2
pubmed:dateRevised	2005-11-16
pubmed:meshHeading	pubmed-meshheading:8124849-Humans, pubmed-meshheading:8124849-Labetalol
pubmed:articleTitle	Labetalol and other agents that block both alpha- and beta-adrenergic receptors.
pubmed:affiliation	Department of Medicine, Louisiana State University School of Medicine, New Orleans 70112.
pubmed:publicationType	Journal Article, Review